[HTML][HTML] Treatment optimisation for hepatitis C in the era of combination direct-acting antiviral therapy: a systematic review and meta-analysis
CR Jones, BF Flower, E Barber, B Simmons… - Wellcome open …, 2019 - ncbi.nlm.nih.gov
Background: Prior to direct-acting antiviral (DAA) therapy, personalised medicine played an
important role in the treatment of hepatitis C virus (HCV). Whilst simplified treatment …
important role in the treatment of hepatitis C virus (HCV). Whilst simplified treatment …
[PDF][PDF] Resistance associated mutations in HCV patients failing DAA treatment
M Di Stefano, G Faleo, AMF Mohamed… - New …, 2021 - newmicrobiologica.org
Currently, treatment of chronic hepatitis C is based on a combination of direct-acting antiviral
agents (DAAs) which achieve HCV clearance in more than 95% of patients. Despite this …
agents (DAAs) which achieve HCV clearance in more than 95% of patients. Despite this …
Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in …
M Kjellin, H Kileng, D Akaberi… - Scandinavian journal …, 2019 - Taylor & Francis
Abstract Background: The NS5A resistance-associated substitution (RAS) Y93H is found
quite frequently (5–10%) at baseline in direct-acting antiviral agents (DAA) treatment-naïve …
quite frequently (5–10%) at baseline in direct-acting antiviral agents (DAA) treatment-naïve …
[HTML][HTML] Machine learning prediction of adenovirus D8 conjunctivitis complications from viral whole-genome sequence
K Nakamichi, L Akileswaran, T Meirick, MD Lee… - Ophthalmology …, 2022 - Elsevier
Objective To obtain complete DNA sequences of adenoviral (AdV) D8 genome from patients
with conjunctivitis and determine the relation of sequence variation to clinical outcomes …
with conjunctivitis and determine the relation of sequence variation to clinical outcomes …
Chronic hepatitis C: Epidemiology, viral resistance, and public health implications
H Kileng - 2019 - munin.uit.no
Chronic hepatitis C: Epidemiology, viral resistance, and public health implications Chronic
hepatitis C virus (HCV) infection can progress to cirrhosis and end-stage liver disease. The …
hepatitis C virus (HCV) infection can progress to cirrhosis and end-stage liver disease. The …
[PDF][PDF] Treatment optimisation for hepatitis C in the era of combination direct-acting antiviral therapy: a systematic review and
Prior to direct-acting antiviral (DAA) therapy, personalised Background: medicine played an
important role in the treatment of hepatitis C virus (HCV). Whilst simplified treatment …
important role in the treatment of hepatitis C virus (HCV). Whilst simplified treatment …
PRIMJENA DIREKTNO DJELUJUĆIH ANTIVIRUSNIH LIJEKOVA (DAA) U LIJEČENJU BOLESNIKA S KRONIČNIM HEPATITISOM CU SPLITSKO-DALMATINSKOJ …
P Maras - 2020 - zir.nsk.hr
Sažetak Cilj: Prevalencija HCV infekcije u Hrvatskoj iznosi 0.9%. Od 2014. godine u
Hrvatskoj su dostupni direktno djelujući antivirusni lijekovi (DAA) za liječenje kronične …
Hrvatskoj su dostupni direktno djelujući antivirusni lijekovi (DAA) za liječenje kronične …
[PDF][PDF] meta-analysis [version 1; peer review: awaiting peer review]
CR Jones, BF Flower, E Barber, B Simmons, GS Cooke - pdfs.semanticscholar.org
Prior to direct-acting antiviral (DAA) therapy, personalised Background: medicine played an
important role in the treatment of hepatitis C virus (HCV). Whilst simplified treatment …
important role in the treatment of hepatitis C virus (HCV). Whilst simplified treatment …